1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Arcosa reported first-quarter 2026 results for continuing operations, with revenue of $571.7 million (up 4%) and Adjusted EBITDA of $102.9 million (up 10%). The company raised its full-year 2026 guidance for continuing operations after completing the sale of its barge business on April 1, 2026, which shareholders may view as a simplified portfolio with higher expected earnings.
Q1 2026 continuing operations: revenue $571.7 million, up 4%; Adjusted EBITDA $102.9 million, up 10%; Adjusted EBITDA margin 18.0%, up 100 basis points
Full-year 2026 Adjusted EBITDA guidance raised to $545 million to $585 million from $520 million to $565 million; revenue guidance raised to $2.6 billion to $2.7 billion from $2.54 billion to $2.67 billion
Barge business sale completed April 1, 2026; $83.0 million of proceeds used in April to prepay part of the term loan
Utility and related structures revenue rose 15% in the quarter; record backlog of $557.6 million at March 31, 2026
Bio-Rad reported first-quarter 2026 net sales of $592.1 million, up 1.1% from a year earlier, but a $738.2 million loss from the change in fair market value of its equity securities and loan receivable led to a GAAP net loss of $527.1 million, or $19.55 per diluted share. The company also lowered its full-year 2026 non-GAAP outlook, which matters to shareholders because the currency-neutral revenue range and operating margin range both moved down.
Q1 2026 net sales were $592.1 million, up 1.1%; currency-neutral sales fell 4.2%.
GAAP net loss was $527.1 million, or $19.55 per diluted share, versus net income of $64.0 million, or $2.29, in Q1 2025.
Non-GAAP diluted earnings per share were $1.89, versus $2.54 a year earlier; free cash flow was $78.1 million.
2026 outlook: currency-neutral revenue now a decline of about 3.0% to growth of about 0.5%, versus prior growth of 0.5% to 1.5%; non-GAAP operating margin now about 10.0% to 12.0%, versus prior 12.0% to 12.5%.
Casella Waste Systems reported first-quarter 2026 revenue of $457.3 million, up 9.6% from a year earlier, and adjusted EBITDA of $97.1 million, up 12.3%, while its net loss widened to $5.5 million from $4.8 million. The company raised its fiscal 2026 guidance for revenue, adjusted EBITDA and adjusted free cash flow, citing acquisitions, but lowered its net income estimate to $4 million to $10 million from $16 million to $22 million.
Q1 2026 revenue was $457.3 million, up $40.2 million from the same period in 2025; net loss was $5.5 million versus $4.8 million a year earlier.
Adjusted EBITDA was $97.1 million, up 12.3%; adjusted free cash flow was $30.7 million, up $1.6 million.
Fiscal 2026 revenue guidance was raised to $2.060 billion to $2.080 billion; adjusted EBITDA guidance was raised to $473 million to $483 million.
Fiscal 2026 net income guidance was lowered to $4 million to $10 million from $16 million to $22 million.
Clorox reported third-quarter fiscal 2026 results for the quarter ended March 31, 2026, with net sales flat at $1.67 billion and adjusted EPS up 13% to $1.64. The company lowered its full-year outlook, now expecting adjusted EPS of $5.45 to $5.65 versus a prior range of $5.95 to $6.30, and gross margin down 250 to 300 basis points, which weighs on shareholder value expectations for the year.
Q3 net sales were $1.67 billion, flat year over year; organic sales decreased 1%; gross margin fell 140 basis points to 43.2%.
Q3 adjusted EPS rose 13% to $1.64; diluted EPS rose 3% to $1.54.
Full-year fiscal 2026 adjusted EPS outlook is $5.45 to $5.65, a decline of 27% to 29%, versus a prior range of $5.95 to $6.30; net sales are now expected to fall about 6%.
The GOJO Industries acquisition closed April 1, 2026; an inventory draw-down tied to the ERP transition is expected to reduce fiscal 2026 EPS by about 90 cents.
Twilio reported first quarter 2026 revenue of $1.41 billion, up 20% year-over-year, and GAAP diluted earnings per share of $0.57 versus $0.12 a year earlier. The company raised its full-year 2026 non-GAAP income from operations range and free cash flow range to $1.08 billion to $1.10 billion each, from $1.04 billion to $1.06 billion, which lifts the outlook for shareholders. Operating cash flow and free cash flow for the quarter were lower than a year earlier.
Q1 revenue of $1.41 billion, up 20% reported and 16% organic; non-GAAP diluted EPS of $1.50 versus $1.14
FY2026 non-GAAP income from operations raised to $1.08 billion to $1.10 billion, from $1.04 billion to $1.06 billion
Q1 free cash flow of $132.3 million versus $178.3 million a year earlier; $253.4 million of shares repurchased in Q1
Q2 2026 revenue guidance of $1.420 billion to $1.430 billion and non-GAAP diluted EPS guidance of $1.27 to $1.32
Universal Display reported first quarter 2026 total revenue of $142.2 million, down from $166.3 million a year earlier, and net income of $35.9 million, or $0.76 per diluted share, down from $64.4 million, or $1.35 per diluted share. The company lowered its 2026 revenue guidance to $630 million to $670 million from $650 million to $700 million, and its board authorized an additional $400 million share repurchase program.
Q1 2026 total revenue was $142.2 million versus $166.3 million in Q1 2025; royalty and license fees fell to $54.2 million from $73.6 million.
Operating income was $42.8 million versus $69.7 million a year earlier.
2026 revenue guidance was revised to $630 million to $670 million, down from $650 million to $700 million.
Board authorized up to $400 million in new buybacks on April 28, 2026, and declared a $0.50 per share dividend payable June 30, 2026.
Ryan Specialty reported first quarter 2026 results for the period ended March 31, 2026. Total revenue rose 15.2% to $795.2 million and net income was $40.6 million, compared with a loss of $4.4 million a year earlier, but operating income fell 5.6% to $94.6 million. The company also updated its 2026 outlook to mid-single-digit organic revenue growth and an Adjusted EBITDAC margin 100 to 150 basis points lower than in 2025, and declared a $0.13 quarterly dividend.
Total revenue grew 15.2% year-over-year to $795.2 million; organic revenue growth was 11.8%, compared with 12.9% a year earlier.
Net income was $40.6 million, or $0.13 per diluted share, versus a loss of $(0.22) per share a year earlier; Adjusted diluted EPS rose 20.5% to $0.47.
2026 guidance: organic revenue growth in the mid-single digits and an Adjusted EBITDAC margin down 100 to 150 basis points versus the prior year.
Quarterly dividend of $0.13 per Class A share declared April 30, 2026, payable May 26, 2026, to holders of record as of May 12, 2026.
SPX Technologies reported first-quarter 2026 revenue of $566.8 million, up 17.4%, and diluted GAAP EPS of $1.27, up 15.5%, with adjusted EPS of $1.69, up 22.5%. The company raised its full-year 2026 guidance for revenue, adjusted EBITDA and adjusted EPS, and total debt rose to $674.0 million from $501.6 at year-end 2025.
Q1 2026 revenue $566.8 million, up 17.4% (7.4% organic); GAAP EPS $1.27, up 15.5%; adjusted EPS $1.69, up 22.5%
2026 adjusted EPS guidance raised to $7.75 to $8.15 from $7.60 to $8.00
2026 adjusted EBITDA guidance raised to $600 million to $625 million from $590 million to $620 million; revenue guidance raised to $2.575 billion to $2.645 billion
Total debt $674.0 million and total cash $158.3 million at March 28, 2026, versus $501.6 million and $366.0 million at December 31, 2025
Healthcare Realty Trust reported first quarter 2026 results on April 30, 2026. Normalized FFO was $0.41 per diluted share, up from $0.39 a year earlier, and the GAAP net loss narrowed to $56 thousand, or $(0.00) per share, from $44.9 million, or $(0.13) per share. Total revenues fell to $279.0 million from $299.0 million, and the company raised its 2026 Normalized FFO guidance to $1.59 to $1.65 per share.
Normalized FFO of $0.41 per diluted share, versus $0.39 in the first quarter of 2025; NAREIT FFO was $0.35 per share in both periods
GAAP net loss of $56 thousand, or $(0.00) per share, versus a net loss of $44.9 million, or $(0.13) per share, a year earlier
Total revenues of $279.0 million, versus $299.0 million in the first quarter of 2025
2026 Normalized FFO guidance raised to $1.59 to $1.65 per share from $1.58 to $1.64; quarterly dividend of $0.24 per share payable May 22, 2026
Tanger reported first-quarter 2026 diluted net income of $0.24 per share, up from $0.17, and FFO of $0.59 per share, up from $0.53, with prior-year results including a $0.04 per share impairment charge. The company raised its full-year 2026 diluted FFO per share estimate to $2.42 to $2.50 from $2.41 to $2.49 and lifted the net income per share range to $1.05 to $1.13, and its board approved a 6.8% dividend increase to $1.25 per share annualized.
Q1 2026 net income available to common shareholders was $28.1 million, or $0.24 per share, versus $19.0 million, or $0.17 per share, a year earlier.
Q1 2026 FFO available to common shareholders was $70.4 million, or $0.59 per share, versus $62.7 million, or $0.53 per share.
2026 diluted FFO per share guidance is $2.42 to $2.50, up from $2.41 to $2.49; diluted net income per share guidance is $1.05 to $1.13, up from $1.04 to $1.12.
Board approved a 6.8% dividend increase to $1.25 per share annualized; quarterly dividend of $0.3125 is payable May 15, 2026.
DiamondRock Hospitality reported first-quarter 2026 results on April 30, 2026, with net income attributable to common stockholders up 54.3% to $14.5 million and total revenues up 1.3% to $258.2 million. The company raised the midpoint of its full-year 2026 guidance, citing better-than-expected first-quarter results and a more favorable insurance renewal, while keeping a measured outlook given geopolitical events and macroeconomic uncertainty. For shareholders, the higher earnings and raised outlook point to improved profitability, though the guidance excludes any dispositions, acquisitions or share repurchases.
Net income attributable to common stockholders was $14.5 million, or $0.07 per diluted share, up 54.3% and 75.0% from the first quarter of 2025.
Full-year 2026 Adjusted EBITDA guidance is now $296 million to $308 million, up from $287 million to $302 million.
Adjusted FFO per diluted share for the quarter was $0.22, up 15.8%; 2026 Adjusted FFO per share guidance is now $1.12 to $1.18.
On April 28, 2026, the board approved a new $300 million share repurchase program; no shares have been repurchased under it yet.
Kirby reported first-quarter 2026 net earnings attributable to Kirby of $81.2 million, or $1.50 per diluted share, up from $76.0 million, or $1.33 per share, a year earlier, on revenue of $844.1 million compared with $785.7 million. The company raised its full-year 2026 earnings per share growth guidance to 5% to 15%, up from 0% to 12%, citing improved marine market conditions and power generation demand.
Q1 2026 diluted EPS $1.50 vs. $1.33; net earnings attributable to Kirby $81.2 million vs. $76.0 million
Total revenues $844.1 million vs. $785.7 million; EBITDA (non-GAAP) $183.1 million vs. $174.3 million
2026 EPS growth guidance raised to 5% to 15% from 0% to 12%; distribution and services operating margin was 6.7% vs. 7.3%
Q1 share repurchases of $52.7 million at an average price of $123.18; stockholders elected three Class I directors on April 27, 2026
AMETEK reported first quarter 2026 sales of $1.93 billion, up 11% from a year earlier, and GAAP diluted earnings of $1.74 per share, up from $1.52. The company raised its full-year 2026 adjusted earnings per share guidance to $7.94 to $8.14, from $7.87 to $8.07, and said it agreed to acquire First Aviation Services, which has annual sales of about $80 million. The guidance increase is positive for shareholders, while the acquisition remains subject to customary closing conditions and regulatory approvals.
Q1 2026 sales were $1.93 billion, up 11%; GAAP diluted EPS was $1.74 versus $1.52 in Q1 2025
Adjusted diluted EPS was $1.97, up 13% from $1.75 in Q1 2025
Full-year 2026 adjusted EPS guidance raised to $7.94 to $8.14 from $7.87 to $8.07; Q2 2026 adjusted EPS guided to $1.96 to $2.00
Agreement to acquire First Aviation Services, with annual sales of approximately $80 million, subject to regulatory approvals
Trinity Industries reported first-quarter 2026 diluted EPS from continuing operations of $0.32, up from $0.29 a year earlier, while revenue fell to $492 million from $585.4 million. The company raised its full-year 2026 EPS guidance to $2.20-$2.40 from $1.85-$2.10, citing higher expected gains on railcar sales, including about $130 million of non-cash pre-tax gain expected in the second quarter from the Napier Park partnership restructuring.
Q1 2026 diluted EPS from continuing operations was $0.32 versus $0.29 in Q1 2025; revenue was $492 million versus $585.4 million.
Full-year 2026 EPS guidance raised to $2.20-$2.40 from $1.85-$2.10, a 16% increase at the midpoint.
Expected non-cash pre-tax gain of about $130 million in Q2 2026 from the Napier Park railcar partnership transaction, closed April 9, 2026.
Series 2026-1 Green Secured Railcar Equipment Notes of $481 million issued April 17, 2026 at a 5.36% all-in interest rate.
National Fuel Gas reported second-quarter fiscal 2026 adjusted EPS of $2.71, up 13% from $2.39 a year earlier, with higher realized natural gas prices driving the Integrated Upstream and Gathering segment. The company also lowered its fiscal 2026 adjusted EPS guidance to $7.45 to $7.75 from $7.60 to $8.10, citing a lower natural gas price assumption and weather-related production delays, which matters to shareholders because the guidance midpoint falls to $7.60 from $7.85.
Second-quarter GAAP EPS was $2.59 on earnings of $247.7 million, compared with $2.37 on $216.4 million a year earlier.
Fiscal 2026 adjusted EPS guidance is now $7.45 to $7.75, down from $7.60 to $8.10 previously.
The NYMEX natural gas price assumption for the remaining six months of fiscal 2026 was cut by $0.75 to $3.00 per MMBtu.
The CenterPoint Energy Ohio natural gas utility acquisition is still expected to close in the fourth quarter of calendar 2026.
Parker Hannifin reported record fiscal third-quarter sales of $5.5 billion, up 11%, and adjusted EPS of $8.17, up 18%. The company raised its fiscal 2026 outlook, now expecting adjusted EPS of $31.20, and GAAP net income and diluted EPS declined year over year because the prior-year period included a one-time $180 million tax benefit.
Q3 sales rose 11% to a record $5.5 billion, with organic sales up 6.5%.
Diluted EPS was $7.06, down from $7.37 a year earlier, which included a one-time $1.37 discrete tax benefit; adjusted EPS rose 18% to a record $8.17.
Fiscal 2026 guidance: EPS of $27.10 ($31.20 adjusted) and reported sales growth of 7%.
Backlog reached a record $12.5 billion, and the company repurchased $275 million of shares in the quarter.
ATI reported first-quarter 2026 sales of $1.15 billion, up 1% from a year earlier, and net income attributable to ATI of $118 million, up 22%. The company raised its full-year 2026 adjusted EPS, adjusted EBITDA and adjusted free cash flow guidance, and its Board authorized an additional $500 million share repurchase, which matters to shareholders because it reflects higher profit and a larger capital return plan, though GAAP results include $26.4 million of pre-tax special charges.
Diluted EPS was $0.85 versus $0.67 a year earlier; adjusted EPS was $1.00 versus $0.72
Full-year 2026 adjusted EPS guidance raised to $4.20-$4.48 from $3.99-$4.27
Full-year adjusted free cash flow guidance raised to $465 million-$525 million from $430 million-$490 million
Board authorized an additional $500 million share repurchase; $545 million remained at end of first quarter
Laureate Education reported first-quarter 2026 revenue of $272.6 million, up 15% as reported but up 1% on a constant currency basis, with an operating loss of $27.5 million compared with $13.2 million a year earlier. The company raised its full-year 2026 Adjusted EPS guidance to $2.00 to $2.08 per share, citing share repurchases of about $105 million in the quarter, while its other 2026 outlook ranges were left unchanged.
Revenue rose 15% to $272.6 million as reported, but only 1% on a constant currency basis; about $9 million of academic calendar timing reduced results.
Net loss widened to $21.6 million from $19.6 million, and Adjusted EBITDA was $(2.3) million versus $5.4 million a year earlier.
Full-year 2026 Adjusted EPS guidance is now $2.00 to $2.08 per share, reflecting 16% to 21% growth as reported; revenue, Adjusted EBITDA and enrollment ranges were reaffirmed.
As of March 31, 2026, cash and cash equivalents were $157.4 million, gross debt was $217.1 million and about $76 million of repurchase authorization remained.
Hilton Grand Vacations reported first quarter 2026 net income attributable to stockholders of $66 million, or $0.79 diluted EPS, compared with a net loss of $17 million a year earlier, on total revenues of $1.285 billion. The company raised its full-year 2026 Adjusted EBITDA outlook, excluding deferrals and recognitions, to $1.225 billion to $1.265 billion from $1.185 billion to $1.225 billion. Results were reduced by a net construction deferral of $18 million, and contract sales were $719 million.
Total revenues were $1.285 billion versus $1.148 billion a year earlier; diluted EPS was $0.79 versus $(0.17).
Full-year 2026 Adjusted EBITDA outlook raised to $1.225 billion to $1.265 billion from $1.185 billion to $1.225 billion.
Repurchased 3.3 million shares for $150 million in the first quarter; $237 million remained under the 2025 Repurchase Plan as of April 23, 2026.
Real Estate Sales and Financing Adjusted EBITDA margin rose to 28.0% from 20.6%, while Resort Operations and Club Management margin fell to 31.8% from 34.0%.
Indivior reported first-quarter 2026 total net revenue of $317 million, up 19% from a year earlier, and GAAP net income of $89 million, or $0.69 per diluted share, versus $47 million, or $0.38, in the prior-year quarter. The company raised its full-year 2026 net revenue and adjusted EBITDA guidance, and said it will not advance two pipeline drugs internally, which shifts the company's focus toward its SUBLOCADE treatment.
Q1 2026 SUBLOCADE net revenue was $232 million, up 32% year over year; total net revenue was $317 million, up 19%.
GAAP net income was $89 million ($0.69 diluted EPS) versus $47 million ($0.38) a year earlier; adjusted EBITDA was $164 million, up 112%.
2026 net revenue guidance was raised to $1,215 million to $1,285 million from $1,125 million to $1,195 million; adjusted EBITDA guidance was raised to $620 million to $660 million from $535 million to $575 million.
Indivior will not pursue Phase 3 development of INDV-6001, and INDV-2000 did not meet its Phase 2 primary endpoint; the company will seek external partners for INDV-2000.
A. O. Smith reported first-quarter 2026 net sales of $945.6 million, down 2%, and net earnings of $118.0 million, down 14%, with diluted EPS of $0.85 versus $0.95 a year earlier. The company lowered its full-year 2026 adjusted EPS outlook to $3.70 to $4.00 from $3.85 to $4.15, which it attributed primarily to continued challenges in China, and narrowed its sales growth outlook to 2% to 4%.
Q1 2026 net sales $945.6 million, down 2% from $963.9 million; net earnings $118.0 million, down 14%; diluted EPS $0.85 versus $0.95
2026 adjusted EPS outlook lowered to $3.70 to $4.00 from $3.85 to $4.15; sales growth outlook revised to 2% to 4% from 2% to 5%
Rest of World sales fell 11% to $200.7 million; China sales fell 17% in local currency
Free cash flow was $118.9 million versus $17.4 million a year earlier; restructuring and impairment expenses of about $20 million are expected in Q2
Kimco Realty reported first quarter 2026 net income available to common shareholders of $157.4 million, or $0.23 per diluted share, up from $0.18 a year earlier, and FFO of $0.46 per diluted share, up 4.5%. The company raised its full-year 2026 net income per diluted share outlook to $0.83 to $0.87 from $0.80 to $0.84, and kept its FFO outlook at $1.81 to $1.84 after a narrower range was moved up at the low end, which matters to shareholders as it reflects higher expected earnings.
Q1 2026 net income per diluted share $0.23 vs. $0.18 in Q1 2025; FFO $311.3 million, or $0.46 per diluted share, vs. $0.44
Full-year 2026 net income per diluted share outlook raised to $0.83 to $0.87 from $0.80 to $0.84; FFO outlook $1.81 to $1.84 vs. $1.80 to $1.84 previously
Same property NOI growth of 1.7% in Q1; full-year outlook raised to +2.8% to +3.5% from +2.5% to +3.5%
Quarterly common dividend declared at $0.26 per share, a 4.0% increase, payable June 18, 2026
Royal Caribbean reported first-quarter 2026 net income of $0.9 billion, or $3.48 per share, up from $2.70 a year earlier, and total revenue of $4.5 billion, up 11%. It also set full-year 2026 Adjusted EPS guidance of $17.10 to $17.50, citing about $0.62 per share of higher fuel costs than prior guidance, partly offset by lower non-fuel costs and share repurchases.
Q1 2026 diluted EPS was $3.48 versus $2.70 in Q1 2025; Adjusted EPS was $3.60 versus $2.71.
Full-year 2026 Adjusted EPS is expected at $17.10 to $17.50, which the company says represents 11% year-over-year growth.
Fuel costs are expected to be about $0.62 per share higher than prior guidance, based on current at-the-pump rates.
Q1 shareholder returns totaled about $1.1 billion, including $836 million of share repurchases and $270 million of dividends.
Brunswick reported first-quarter 2026 net sales of $1,378.1 million, up 12.8% from a year earlier, and adjusted diluted EPS of $0.70, up 25%. The company raised its full-year 2026 adjusted diluted EPS guidance to $4.00 to $4.50, but GAAP operating earnings fell 10.7% to $50.3 million and free cash flow was negative $116.8 million for the quarter.
Q1 2026 GAAP diluted EPS was $0.32, up 6.7%; adjusted diluted EPS was $0.70, up 25%.
Full-year 2026 guidance: net sales $5.65 billion to $5.8 billion, adjusted diluted EPS $4.00 to $4.50, free cash flow $350 million or more.
Q1 GAAP operating earnings were $50.3 million, down 10.7%, including a $10.4 million supplier bankruptcy expense.
Q2 2026 guidance: revenue of $1.45 billion to $1.55 billion and adjusted diluted EPS of $1.10 to $1.20.
Benchmark Electronics reported first quarter 2026 revenue of $677 million, up from $632 million a year earlier, and diluted GAAP EPS of $0.36, up from $0.10. The company raised its full-year 2026 revenue growth outlook to 9-10%, from prior expectations of mid-single-digit growth, and gave second quarter guidance of $700 million to $740 million in revenue.
Q1 2026 revenue $677 million vs. $632 million in Q1 2025 and $704 million in Q4 2025
Diluted GAAP EPS $0.36 vs. $0.10 a year earlier; non-GAAP diluted EPS $0.58 vs. $0.52
Full-year 2026 revenue growth outlook raised to 9-10%, from mid-single digits
Q2 2026 guidance: revenue $700 million to $740 million; non-GAAP diluted EPS $0.65 to $0.71
Equinix reported first-quarter 2026 revenue of $2.444 billion, up 10% from a year earlier, with net income of $415 million and diluted EPS of $4.20, up 20%. The company raised its full-year 2026 guidance, including revenue of $10.144 to $10.244 billion and AFFO per share of $42.31 to $43.11, which shareholders can compare with the prior ranges.
Q1 2026 revenue was $2.444 billion, up 10% as reported and 8% on a normalized, constant-currency basis.
Q1 net income attributable to common stockholders was $415 million, up 21%, and diluted EPS was $4.20, up 20%.
Q1 AFFO per diluted share was $10.79, up 12%; adjusted EBITDA was $1.245 billion at a 51% margin.
Full-year 2026 AFFO per share guidance was raised to $42.31 to $43.11 from $41.93 to $42.74; Q2 2026 revenue guidance is $2.571 to $2.611 billion.
Glaukos reported record first-quarter 2026 net sales of $150.6 million, up 41% from a year earlier, while its GAAP net loss widened slightly to $19.8 million. The company raised its full-year 2026 net sales guidance to $620 million to $635 million from $600 million to $620 million.
Q1 2026 net sales were $150.6 million, up from $106.7 million in Q1 2025 (41% reported, 39% constant currency).
GAAP net loss was $19.8 million, or $0.34 per diluted share, versus $18.1 million, or $0.32 per diluted share, a year earlier.
2026 net sales guidance raised to $620 million to $635 million, from $600 million to $620 million previously.
Cash, cash equivalents, short-term investments and restricted cash totaled $280.5 million as of March 31, 2026, with no debt.
Farmland Partners reported first-quarter 2026 net income of $0.6 million, or $0.01 per share, down from $2.1 million, or $0.03 per share, a year earlier. Total operating revenues were $10.1 million, down 1.5%, and the company reduced its 2026 AFFO per share guidance, citing non-cash allowances for potential loan losses under its FPI loan program. For shareholders, the lower earnings and guidance cut outweigh the 50% dividend increase and the redemption of the remaining Series A preferred units.
Q1 2026 net income was $0.6 million ($0.01 per share) versus $2.1 million ($0.03 per share) in Q1 2025; AFFO was $2.1 million ($0.05 per share), versus $2.3 million ($0.05 per share).
2026 AFFO per share earnings guidance decreased from the prior quarter; the filing points to page 15 of the supplemental package for details.
The board declared a quarterly dividend of $0.09 per share on April 28, 2026, payable July 15, 2026; the annualized rate was raised 50% in February.
Woodward reported second quarter fiscal 2026 net sales of $1.1 billion, up 23%, and diluted EPS of $2.19, up 23% from the prior year. The company raised its full-year 2026 guidance, with adjusted EPS now expected at $9.15 to $9.45, up from $8.20 to $8.60, which signals higher expected earnings for shareholders.
Q2 net earnings were $134 million and adjusted EPS was $2.27, up 34% from the prior year period.
FY26 adjusted EPS guidance rose to $9.15-$9.45 from $8.20-$8.60 issued on February 2, 2026; sales growth guidance rose to 20%-23% from 14%-18%.
Q2 free cash flow was $38 million, down 36%, as capital expenditures rose to $53 million from $18 million.
Share repurchases totaled $226 million in the quarter and $355 million year to date.
IDEX reported first quarter 2026 net sales of $886.9 million, up 9% on a reported basis and 5% organically, and reported diluted EPS of $1.61, up from $1.26. The company raised its full-year 2026 organic sales and adjusted diluted EPS guidance, which signals higher expected earnings for shareholders.
Q1 2026 net sales of $886.9 million rose 9% reported and 5% organically; reported diluted EPS was $1.61 versus $1.26 a year earlier.
Full-year 2026 organic sales growth guidance raised to 3% to 4%, up from 1% to 2%.
Full-year 2026 adjusted diluted EPS guidance raised to $8.35 to $8.55, up from $8.15 to $8.35.
Gross margin fell to 44.9% from 45.3%; the company repurchased $76 million of shares and paid $53 million in dividends in the quarter.
OneSpaWorld reported first quarter 2026 results, with total revenues up 13% to $247.6 million and net income up 40% to $21.3 million from the first quarter of 2025. The company raised its full-year 2026 guidance for total revenues and Adjusted EBITDA, and its Board declared a $0.05 per share quarterly dividend.
Total revenues rose 13% to $247.6 million, and net income rose 40% to $21.3 million, or $0.21 per diluted share, versus $0.15 a year earlier.
Adjusted EBITDA rose 21% to $32.2 million from $26.6 million in the first quarter of 2025.
FY 2026 guidance: total revenues of $1.014 to $1.034 billion and Adjusted EBITDA of $129.0 to $139.0 million, compared with prior guidance of $1.010 to $1.030 billion and $128.0 to $138.0 million.
Quarterly dividend of $0.05 per share is payable June 3, 2026; no shares were repurchased in the first quarter of 2026.
Generac reported first-quarter 2026 net income of $73 million, or $1.24 per diluted share, up from $44 million, or $0.73, a year earlier. The company also raised its full-year 2026 net sales growth and adjusted EBITDA margin outlook, citing data center backlog and the Enercon acquisition, and it reorganized its reporting into Residential and Commercial & Industrial segments. Gross profit margin fell to 38.7% from 39.5%.
Net sales rose 12% to $1.06 billion from $942 million; Commercial & Industrial sales rose about 28% to $510 million.
Adjusted net income was $106 million, or $1.80 per diluted share, versus $1.26 a year earlier.
2026 net sales growth outlook raised to mid-to-high teens percent from mid-teens percent; adjusted EBITDA margin outlook raised to 18.5% to 19.5% from 18.0% to 19.0%.
Enercon acquisition was completed on April 1, 2026, after Allmand was completed on January 5.
Constellium reported first-quarter 2026 revenue of $2.5 billion, up 24% from a year earlier, and net income of $196 million, compared with $38 million in the first quarter of 2025. The company raised its 2026 guidance to Adjusted EBITDA of $900 million to $940 million, excluding the non-cash impact of metal price lag, and Free Cash Flow above $275 million.
Adjusted EBITDA was $359 million, up from $186 million, including a non-cash metal price lag benefit of $97 million.
Diluted earnings per share were $1.42, compared with $0.26 in the first quarter of 2025.
Free Cash Flow was $5 million, and the company repurchased 1.2 million shares for $28 million.
Leverage was 2.2x at March 31, 2026, and the 2026 Free Cash Flow guidance is above $275 million.
Biogen reported first quarter 2026 total revenue of $2.5 billion, up 2% year over year, and non-GAAP diluted EPS of $3.57, up 18%. The company lowered its full-year 2026 non-GAAP diluted EPS guidance to $14.25 to $15.25 from $15.25 to $16.25, citing an approximately $1.00 impact from acquired IPR&D charges, and said it plans to announce updated guidance including the proposed Apellis acquisition with its second quarter results.
Q1 2026 total revenue was $2,478 million, up 2% year over year; GAAP diluted EPS was $2.15, up 31%.
Full-year 2026 non-GAAP diluted EPS guidance is now $14.25 to $15.25, down from $15.25 to $16.25 in February 2026, excluding the Apellis transaction.
Biogen proposed acquiring Apellis Pharmaceuticals, subject to customary closing conditions, with closing expected in the second quarter of 2026.
First quarter cash flow from operations was approximately $646 million, and net debt was approximately $1.5 billion as of March 31, 2026.
Jack Henry & Associates reported deconversion revenue of $18.7 million for the fiscal third quarter ended March 31, 2026, and raised its full-year fiscal 2026 deconversion revenue estimate to $37 million. The company says deconversion revenue mainly arises when a client is acquired by another financial institution, is driven by factors outside its control, and is excluded from its non-GAAP revenue.
Fiscal Q3 2026 deconversion revenue was $18.7 million, for the quarter ended March 31, 2026.
Full-year fiscal 2026 deconversion revenue estimate increased to $37 million.
Deconversion revenue is excluded from non-GAAP revenue in Jack Henry's quarterly and annual earnings releases.
The release was issued April 28, 2026, as Exhibit 99.1 to a Form 8-K.
Ashland reported second-quarter fiscal 2026 sales of $482 million, up one percent, but Adjusted EBITDA fell nine percent to $98 million and net income dropped to $16 million from $31 million. The company updated its full-year fiscal 2026 guidance to sales of $1,835 million to $1,870 million and Adjusted EBITDA of $385 million to $400 million, citing a slower-than-expected productivity ramp at its Hopewell facility.
Q2 sales $482 million, up one percent; pricing declined two percent
Q2 Adjusted EBITDA $98 million, down nine percent from $108 million; net income $16 million vs. $31 million
Full-year fiscal 2026 Adjusted EBITDA guidance $385 million to $400 million; sales guidance $1,835 million to $1,870 million
Fiscal 2026 manufacturing optimization savings expectations reduced by approximately $10 million to $12 million
Veralto reported first-quarter 2026 sales of $1,422 million, up 6.7% from a year earlier, and GAAP diluted EPS of $1.02 versus $0.90 a year earlier. The company raised its full-year 2026 adjusted EPS guidance to $4.20 to $4.28 from $4.10 to $4.20, which is a positive signal for shareholders, though it also launched a cost program with a $85 million to $105 million charge.
Q1 sales rose 6.7% to $1,422 million, with non-GAAP core sales growth of 1.9%
GAAP net earnings were $254 million, or $1.02 per diluted share; adjusted EPS was $1.07 versus $0.95 a year earlier
Full-year 2026 adjusted EPS guidance raised to $4.20 to $4.28; second-quarter adjusted EPS guidance is $0.96 to $1.00
Year-to-date capital allocation of about $1 billion included about $620 million in acquisitions and $300 million in share repurchases
ONEOK reported first-quarter 2026 net income of $776 million, up 12% from a year earlier, and diluted earnings of $1.23 per share. The company also raised its 2026 guidance, with adjusted EBITDA now expected between $8.0 billion and $8.5 billion, which matters to shareholders because it signals higher expected earnings for the year.
Q1 2026 net income rose 12% to $776 million; diluted EPS was $1.23, versus $1.04 a year earlier
Q1 2026 adjusted EBITDA rose 13% to $2.0 billion
2026 net income guidance raised to a range of $3.21 billion to $3.79 billion; adjusted EBITDA guidance raised to $8.0 billion to $8.5 billion
Q1 2026 results include a $60 million noncash impairment of a joint-venture investment, or 7 cents per diluted share
Acadia Realty Trust reported first quarter 2026 GAAP net earnings of $0.22 per share, up from $0.01 a year earlier, driven mainly by gains on sale of $0.22 per share. Its NAREIT FFO fell to $36.9 million ($0.26 per share) from $44.6 million ($0.34), while FFO As Adjusted rose to $41.8 million ($0.30 per share) from $35.1 million ($0.27). The company raised its 2026 EPS guidance to $0.37-$0.39 from $0.24-$0.26 and its FFO As Adjusted guidance to $1.22-$1.26 from $1.21-$1.25.
GAAP net earnings of $0.22 per share vs. $0.01 in Q1 2025, mainly from gains on sale of $0.22 per share
NAREIT FFO of $36.9 million ($0.26 per share) vs. $44.6 million ($0.34) a year earlier
FFO As Adjusted of $41.8 million ($0.30 per share) vs. $35.1 million ($0.27); same-property NOI up 5.9%
2026 EPS guidance raised to $0.37-$0.39 from $0.24-$0.26; FFO As Adjusted guidance raised to $1.22-$1.26 from $1.21-$1.25
EXL reported first-quarter 2026 revenue of $570.4 million, up 13.8% from a year earlier, and GAAP diluted EPS of $0.43, up from $0.40. The company raised its full-year 2026 guidance for both revenue and adjusted diluted EPS, which signals management's expectation of stronger results for the year.
Q1 2026 revenue was $570.4 million, up 13.8% from $501.0 million (13.4% on a constant currency basis).
GAAP diluted EPS was $0.43 versus $0.40; adjusted diluted EPS was $0.58 versus $0.48.
Full-year 2026 revenue guidance raised to $2.30 billion to $2.33 billion from $2.275 billion to $2.315 billion.
Adjusted diluted EPS guidance raised to $2.18 to $2.23 from $2.14 to $2.19; conference call set for April 29, 2026 at 10:00 A.M. ET.
Welltower reported first-quarter 2026 results on April 28, 2026. Normalized FFO attributable to common stockholders rose to $1.47 per diluted share from $1.20 a year earlier, and total revenues rose to $3.35 billion from $2.42 billion. The company raised its 2026 guidance for both net income and normalized FFO per diluted share.
Q1 2026 net income attributable to common stockholders was $1.02 per diluted share, versus $0.40 in Q1 2025.
2026 net income guidance raised to $3.24 to $3.38 per diluted share from $3.11 to $3.27.
2026 normalized FFO guidance raised to $6.21 to $6.35 per diluted share from $6.09 to $6.25.
Board declared a quarterly dividend of $0.74 per share, payable May 21, 2026.
Applied Industrial Technologies reported fiscal third-quarter net sales of $1.3 billion, up 7.3% from a year earlier, and diluted EPS of $2.65 versus $2.57. The company raised its fiscal 2026 EPS guidance low end to $10.64 from $10.45 and its total sales growth guidance to 7.2% to 7.7%, and its Board authorized a new buyback of up to 3.0 million shares.
Q3 net sales $1.3 billion, up 7.3%; organic sales up 6.0% year over year
Diluted EPS $2.65 vs. $2.57 a year earlier; net income $99.8 million
FY26 EPS guidance $10.64 to $10.75 (prior $10.45 to $10.75); total sales growth 7.2% to 7.7% (prior 5.5% to 7.0%)
Board authorized repurchase of up to 3.0 million shares; quarterly dividend of $0.51 payable May 29, 2026
American Tower reported first-quarter 2026 results on April 28, 2026, with total revenue up 6.8% to $2,738 million and net income up 76.2% to $879 million. The company raised the midpoints of its full-year 2026 outlook for AFFO attributable to common stockholders, Adjusted EBITDA and property revenue, citing favorable currency movements and straight-line revenue in Latin America. The filing also notes that the net income increase was affected by foreign currency gains compared with losses a year earlier.
Q1 2026 total revenue rose 6.8% to $2,738 million; AFFO attributable to common stockholders rose 2.6% to $1,324 million.
Net income rose 76.2% to $879 million, with growth affected by foreign currency gains of about $68.1 million versus $345.7 million of losses a year earlier.
Full-year 2026 AFFO midpoint raised by $55 million and Adjusted EBITDA midpoint raised by $105 million; AFFO range is $5,090 million to $5,170 million.
Net leverage ratio was 4.9x at March 31, 2026; the company repurchased about 1.1 million shares for about $184 million in the first quarter.
Curbline Properties reported first-quarter 2026 net income attributable to the company of $3.6 million, or $0.03 per diluted share, down from $10.6 million, or $0.10, a year earlier. Operating FFO rose to $29.9 million, or $0.28 per diluted share, from $25.1 million, or $0.24, and the company raised its 2026 Operating FFO guidance to $1.20 to $1.23 per share from $1.17 to $1.21, while lowering its net income per share guidance to $0.29 to $0.36 from $0.32 to $0.40.
Q1 2026 net income attributable to Curbline was $3.6 million, or $0.03 per diluted share, versus $10.6 million, or $0.10, in Q1 2025.
Q1 2026 Operating FFO was $29.9 million, or $0.28 per diluted share, versus $25.1 million, or $0.24, in Q1 2025.
2026 Operating FFO guidance was raised to $1.20 to $1.23 per diluted share; net income guidance was lowered to $0.29 to $0.36.
Same-property NOI rose 4.8% in Q1 2026, and the company acquired 14 shopping centers for $142.4 million during the quarter.
Zimmer Biomet reported first-quarter 2026 net sales of $2.087 billion, up 9.3% from the prior year, and diluted earnings per share of $1.22, up 34.1%. The company raised its full-year 2026 adjusted diluted EPS guidance to $8.40-$8.55 from $8.30-$8.45, while its reported revenue change guidance of 2.5%-4.5% was unchanged. The company's goodwill impairment assessment is not yet complete, and any charge would change first-quarter GAAP net earnings.
Net sales $2.087 billion, up 9.3% reported and 2.9% on an organic constant currency basis
Diluted EPS $1.22 versus $0.91; adjusted diluted EPS $2.09, up 15.5%
2026 adjusted diluted EPS guidance raised to $8.40-$8.55 from $8.30-$8.45
Operating cash flow $359.4 million and free cash flow $245.9 million; $250 million of share repurchases in the quarter
Kilroy Realty reported a first-quarter 2026 net loss available to common stockholders of $19.3 million, or $0.16 per diluted share, compared with net income of $39.0 million, or $0.33 per share, a year earlier. The loss reflects a $61.8 million impairment charge, while funds from operations (FFO) fell to $108.8 million, or $0.91 per diluted share, and the company raised its full-year 2026 FFO guidance to $3.49 to $3.63 per diluted share from $3.25 to $3.45.
Net loss available to common stockholders of $(19.3) million, or $(0.16) per diluted share, versus net income of $39.0 million, or $0.33, in Q1 2025; the quarter included a $61.8 million impairment of real estate assets
FFO of $108.8 million, or $0.91 per diluted share, versus $122.3 million, or $1.02, a year earlier; revenues were $270.1 million versus $270.8 million
Full-year 2026 FFO per diluted share guidance raised to $3.49 to $3.63 from $3.25 to $3.45
Signed approximately 568,000 square feet of leases in Q1; repaid $50.0 million of 4.300% senior notes in April 2026
Ventas reported first-quarter 2026 results that improved year over year, with total revenue of $1.66 billion, up from $1.36 billion, and normalized FFO of $0.94 per share, up from $0.86. The company raised its full-year 2026 guidance for per share Attributable Net Income, Nareit FFO and Normalized FFO, and increased its 2026 senior housing investment target to $3 billion.
Q1 2026 Attributable Net Income was $0.11 per diluted share, up from $0.10 a year earlier; Normalized FFO was $0.94, up from $0.86
Full-year 2026 Normalized FFO guidance midpoint rose to $3.86 per share from $3.83; the range is now $3.82 to $3.89
2026 investment volume expectation increased to $3 billion from $2.5 billion; $1.7 billion of senior housing investments closed year to date through April 2026
Net Debt-to-Further Adjusted EBITDA was 5.0x at March 31, 2026, and liquidity was $5.5 billion
Brixmor reported first-quarter 2026 net income attributable to the company of $127.8 million, or $0.41 per diluted share, up from $69.7 million, or $0.23 per diluted share, a year earlier, on total revenues of $354.8 million versus $337.5 million. The company raised the low end of its 2026 Nareit FFO per diluted share outlook to $2.34-$2.37 from $2.33-$2.37 and raised same property NOI growth expectations to 4.75%-5.50% from 4.50%-5.50%.
Net income attributable to Brixmor was $0.41 per diluted share for the quarter ended March 31, 2026, versus $0.23 a year earlier, and included a $52.1 million gain on sale of real estate assets.
Nareit FFO was $179.6 million, or $0.58 per diluted share, versus $0.56 a year earlier; same property NOI rose 6.4%.
2026 Nareit FFO per diluted share outlook is $2.34-$2.37, up from $2.33-$2.37; same property NOI growth outlook is 4.75%-5.50%, up from 4.50%-5.50%.
The board declared a quarterly dividend of $0.3075 per share, payable July 15, 2026 to holders of record on July 2, 2026.
Cadence reported first-quarter 2026 revenue of $1.474 billion, up from $1.242 billion a year earlier, and non-GAAP diluted earnings of $1.96 per share, up from $1.57. The company raised its full-year 2026 revenue outlook to $6.125 billion to $6.225 billion, from a prior range of $5.900 billion to $6.000 billion, and reported a record backlog of $8.0 billion.
Q1 2026 revenue of $1.474 billion vs. $1.242 billion in Q1 2025
Q1 2026 GAAP diluted EPS of $1.23 vs. $1.00; non-GAAP diluted EPS of $1.96 vs. $1.57
FY 2026 revenue outlook raised to $6.125 billion-$6.225 billion from $5.900 billion-$6.000 billion
Quarter-end backlog of $8.0 billion; about $200 million planned for share repurchases in Q2 2026
Chemed reported first-quarter 2026 revenue up 1.6% to $657.5 million, with GAAP diluted EPS of $4.84, down 0.4%, and adjusted diluted EPS of $5.65, up 0.4%. The company raised its full-year 2026 adjusted EPS guidance to $24.00 to $24.75 from $23.25 to $24.25, citing stronger VITAS performance and share repurchases.
Q1 2026 revenue rose 1.6% to $657.5 million; GAAP diluted EPS was $4.84, down 0.4%, and adjusted diluted EPS was $5.65, up 0.4%.
Full-year 2026 adjusted EPS guidance raised to $24.00 to $24.75 from $23.25 to $24.25.
VITAS anticipated ADC growth raised to 4.5% to 5.5% from 3.5% to 4.0%; Roto-Rooter adjusted EBITDA margin guidance lowered to 21.5% to 22.5% from 22.5% to 23.0%.
Repurchased 500,000 shares for $197.7 million in the quarter; about $229.6 million of authorization remained as of March 31, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.